Drug
Rufinamide clinical trials
Also written E2080.
- studies test it
- 10
- open now
- 0
- in phase 3
- 6
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 3
Eisai Inc. (3) · Daiichi Sankyo (1) · Eisai Co., Ltd. (1) · Biotie Therapies Inc. (1) · Eisai Limited (1) · Wuhan Union Hospital, China (1) · University of South Alabama (1) · University of Zurich (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses rufinamide is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy SubjectsCompletedPhase 1Daiichi SankyoNCT06740825Written as Rufinamide
- Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial SeizuresCompletedPhase 3Eisai Inc.NCT00334958Written as Rufinamide
- Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With SeizuresWithdrawnPhase 3University of South AlabamaNCT04558580Written as Rufinamide
- Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial SeizuresTerminatedPhase 3Eisai Inc.NCT00448539Written as Rufinamide
- Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic DrugsCompletedPhase 3Eisai Inc.NCT01405053Written as Rufinamide
- A Long Term Extension Study of E2080 in Lennox-Gastaut PatientsCompletedPhase 3Eisai Co., Ltd.NCT01151540Written as Rufinamide
- Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)CompletedPhase 2Biotie Therapies Inc.NCT00595231Written as SYN111
- A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)CompletedPhase 3Eisai LimitedNCT01146951Written as Rufinamide (E2080)
- Effect of Rufinamide on Chronic Postthoracotomy Pain SyndromeWithdrawnPhase 2University of ZurichNCT02095899Written as Rufinamide
- Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese SubjectsCompletedPhase 1Wuhan Union Hospital, ChinaNCT02332174Written as rufinamide
Codes
What other systems call rufinamide · ClinicalTrials.gg INT003707
- MeSH (NLM) C079703rufinamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) WFW942PR79RUFINAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 69036Confirmed FDA, Wikidata
- Wikidata Q408565rufinamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75167RufinamideOne source FDA
- DrugBank DB06201One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C079703 | rufinamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | WFW942PR79 | RUFINAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 69036 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408565 | rufinamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75167 | Rufinamide | One source FDA |
| DrugBank | DB06201 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.